Our previous study found that the mucus layer got thicker and the expressions of mucin MUC2 and TJs (e.g., Claudin1 and ZO-1) were enhanced after supplementation with LBP-3 (arabinogalactan type) in DSS-induced colitis, thereby improving the intestinal barrier function [78]. Here, MUC2 is linked to colitis.